This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • it is usually too late to alter the course of the illness in immunocompetent patients who present with Herpes labialis.
  • management consists of:
    • treatment
      • look for any underlying infection which may have precipitated the cold sore
      • consider acyclovir cream - although for maximal clinical benefit the treatment should begin as early as possible
      • systemic antivirals use for herpes labialis generally should be reserved for those who are immunocompromised (1)
    • prevention
      • advice as to how the virus is transmitted - kissing is probably the most important method and patients should be encouraged to avoid kissing non-affected relative
      • avoid sharing cups, or lip balms (2)
      • area of the body where there is a herpes infection should be kept away from other people (2)
      • advise on ways to reduce further recurrence - for example, suncreams in patients who get bad attacks in sunlight

Public Health England guidance states (3):

  • most resolve after 5 days without treatment
  • topical antivirals applied prodromally can reduce duration by 12 to 18 hours
  • if frequent, severe, and predictable triggers:
    • consider oral prophylaxis: aciclovir 400mg, twice daily, for 5 to 7 days

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.